| 股票代码 | 603658 | 当期评分 | ||||
| 股票名称 | 安图生物 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.99 | 1.147 | 1.5565 | 2.0069 | 0.745 | ✘ |
| 销售净利润率(%) | 35.6815 | 32.1172 | 29.7982 | 29.3681 | 25.3966 | ✔ |
| 销售毛利率(%) | 70.3562 | 66.1598 | 65.1318 | 65.5705 | 59.4555 | ✔ |
| 净资产收益率(%) | 21.26 | 26.78 | 29.17 | 30.28 | 16.14 | ✘ |
| 营业增长率(%) | 36.8093 | 42.8391 | 37.82 | 38.8542 | 8.1175 | ✘ |
| 净利润增长率(%) | 25.8001 | 28.5709 | 27.8686 | 36.8501 | -5.1369 | ✘ |
| 每股收益(%) | 0.89 | 1.06 | 1.34 | 1.84 | 1.2 | ✔ |
| 现金流量比率(%) | 280.3044 | 112.6369 | 107.0296 | 85.3954 | 19.6102 | ✔ |
| 三项费用比重(%) | 29.7892 | 31.5859 | 21.3636 | 21.9446 | 21.6031 | ✔ |
| 每股净资产(¥) | 3.9165 | 3.9697 | 4.5919 | 6.0879 | 7.3987 | ✔ |
| 流动比率(%) | 7.9213 | 2.1364 | 1.8131 | 2.0438 | 1.4314 | ✔ |
| 速动比率(%) | 7.2976 | 1.6839 | 1.3934 | 1.6971 | 1.1113 | ✔ |
| 现金比率(%) | 37.8925 | 6.2979 | 9.4318 | 13.868 | 13.868 | ✔ |
| 总资产利润率(%) | 25.2806 | 22.4352 | 23.7416 | 22.7643 | 11.0543 | ✔ |
| 主营利润比重% | 169.1204 | 179.8594 | 192.013 | 198.3556 | 207.9272 | ✔ |
| 应收账款(万元) | 16,161.69 | 22,436.70 | 34,548.34 | 63,447.93 | 96,179.82 | ✘ |
| 应收票据(万元) | 46.63 | 44.69 | 5.16 | -- | -- | ✘ |
| 预付款项(万元) | 6,228.38 | 6,024.88 | 8,067.26 | 12,603.13 | 16,624.61 | ✔ |
| 存货(万元) | 9,252.97 | 19,352.56 | 25,635.77 | 34,221.94 | 52,360.08 | ✘ |
| 在建工程(万元) | 13,907.60 | 25,053.02 | 20,143.43 | 32,956.20 | 60,307.68 | ✔ |
| 应付款项(万元) | 2,831.30 | 6,904.19 | 8,950.09 | 18,080.02 | 20,876.09 | ✔ |
| 长期借款(万元) | -- | 3,402.00 | 4,229.00 | -- | -- | ✔ |
| 未分配利润(万元) | 58,869.38 | 56,492.86 | 76,750.35 | 120,059.35 | 132,735.21 | ✔ |
| 商誉(万元) | 3.23 | 16,464.85 | 16,464.85 | 17,102.54 | 16,464.85 | ✔ |
| 流动资产(万元) | 64,635.40 | 127,362.55 | 154,914.91 | 223,958.40 | 280,889.78 | ✔ |
| 流动负债(万元) | 14,834.46 | 42,768.51 | 61,079.03 | 98,703.98 | 163,585.12 | ✔ |
安图生物603658评分结果 | 63.64分 | 卖出/减持 | ||||